朗詩地產(00106.HK)收購邁皋橋項目權益
朗詩地產(00106.HK)公布,於12月18日公司全資附屬南京朗銘、西安嘉鵬、民生加銀及南京鑫輝盛訂立股權轉讓協議,民生加銀作為資產管理人代民生加銀資產管理計劃同意轉讓南京鑫輝盛全部股權,及南京朗銘及西安嘉鵬同意分別收購南京鑫輝盛74%及26%股權,總代價為5.32億元人民幣,南京朗銘將支付其中3.94億元。
於轉讓完成後,集團持有南京鑫輝盛74%股權,南京鑫輝盛將繼續為公司附屬公司及其財務業績會繼續合併至公司綜合財務報表。南京鑫輝盛持股49.9%項目公司持有邁皋橋地塊權益,其已發展為商業性住宅項目,該項目已基本售罄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.